Search results for "INFECTIONS"

showing 10 items of 2671 documents

Polyclonal non multiresistant methicillin resistant Staphylococcus aureus isolates from clinical cases of infection occurring in Palermo, Italy, duri…

2012

Abstract Background The evolving epidemiology of methicillin resistant Staphylococcus aureus (MRSA) is characterized by the emergence of infections caused by non multiresistant MRSA carrying staphylococcal chromosomal cassette (SCC)mec IV or V in the healthcare settings. A molecular epidemiological analysis of non multiresistant MRSA isolates from four acute general hospitals was performed in Palermo, Italy, during a one year period. Methods For the purpose of the study, MRSA isolates were defined as non multiresistant when they were susceptible to at least three classes of non β-lactam antibiotics. Seventy-five isolates were submitted to antimicrobial susceptibility testing, multilocus seq…

Methicillin-Resistant Staphylococcus aureusMicrobiology (medical)medicine.medical_specialtylcsh:QR1-502Microbial Sensitivity TestsDrug resistanceTigecyclineBiologyStaphylococcal infectionsmedicine.disease_causelcsh:MicrobiologyMicrobiologylcsh:Infectious and parasitic diseasesMedical microbiologyDrug Resistance Multiple BacterialmedicineHumanslcsh:RC109-216Researchlcsh:RM1-950General MedicineStaphylococcal Infectionsbiochemical phenomena metabolism and nutritionmedicine.diseasebacterial infections and mycosesMethicillin-resistant Staphylococcus aureusVirologyAnti-Bacterial AgentsInfectious Diseaseslcsh:Therapeutics. PharmacologyItalyMultilocus sequence typingMethicillin ResistanceDaptomycinPanton–Valentine leukocidinSentinel SurveillanceMultilocus Sequence Typingmedicine.drugAnnals of Clinical Microbiology and Antimicrobials
researchProduct

New linezolid-like 1,2,4-oxadiazoles active against Gram-positive multiresistant pathogens

2013

The synthesis and the in vitro antibacterial activity of novel linezolid-like oxadiazoles are reported. Replacement of the linezolid morpholine C-ring with 1,2,4-oxadiazole results in an antibacterial activity against Staphylococcus aureus both methicillin-susceptible and methicillin-resistant comparable or even superior to that of linezolid. While acetamidomethyl or thioacetoamidomethyl moieties in the C(5) side-chain are required, fluorination of the phenyl B ring exhibits a slight effect on an antibacterial activity but its presence seems to reduce the compounds cytotoxicity. Molecular modeling performed using two different approaches - FLAP and Amber software - shows that in the binding…

Methicillin-Resistant Staphylococcus aureusModels MolecularCell viabilityStaphylococcus aureusMolecular modelCell SurvivalMicrobial Sensitivity TestsAntimicrobial activityCrystallography X-Raymedicine.disease_causeDrug designMicrobiologyStructure-Activity Relationshipchemistry.chemical_compoundoxadiazoles linezolid antibioticsCell Line TumorDrug Resistance Multiple BacterialMorpholineAcetamidesDrug DiscoverymedicineHumansMoietyStructure–activity relationshipOxazolidinonesPharmacologyOxadiazolesOxazolidinones; Linezolid; Drug designDose-Response Relationship DrugMolecular StructureChemistryOrganic ChemistryLinezolidSettore CHIM/06 - Chimica OrganicaHep G2 CellsGeneral Medicinebiochemical phenomena metabolism and nutritionbacterial infections and mycosesSettore CHIM/08 - Chimica FarmaceuticaMethicillin-resistant Staphylococcus aureusCombinatorial chemistryOxazolidinoneAnti-Bacterial AgentsStaphylococcus aureusMED/07 - MICROBIOLOGIA E MICROBIOLOGIA CLINICALinezolidAntimicrobial activity; Cell viability; Drug design; Oxazolidinones; Staphylococcus aureusAntibacterial activitySoftware
researchProduct

Therapeutic Strategies To Counteract Antibiotic Resistance in MRSA Biofilm‐Associated Infections

2021

Methicillin-resistant Staphylococcus aureus (MRSA) has emerged as one of the leading causes of persistent human infections. This pathogen is widespread and is able to colonize asymptomatically about a third of the population, causing moderate to severe infections. It is currently considered the most common cause of nosocomial infections and one of the main causes of death in hospitalized patients. Due to its high morbidity and mortality rate and its ability to resist most antibiotics on the market, it has been termed a “superbug”. Its ability to form biofilms on biotic and abiotic surfaces seems to be the primarily means of MRSA antibiotic resistance and pervasiveness. Importantly, more tha…

Methicillin-Resistant Staphylococcus aureusmedicine.medical_specialtymedicine.drug_classMRSA biofilm antibiotic-resistance antivirulence strategy eradicating agentsAntibioticsPopulationbeta-Lactamsmedicine.disease_cause01 natural sciencesBiochemistryHigh morbidityAntibiotic resistanceDrug Resistance BacterialDrug DiscoveryHumansMedicineGeneral Pharmacology Toxicology and PharmaceuticsIntensive care medicineeducationProtein Kinase InhibitorsPathogenOxazolidinonesPharmacologyeducation.field_of_study010405 organic chemistrybusiness.industryMortality rateOrganic ChemistryBiofilmStaphylococcal Infectionsbiochemical phenomena metabolism and nutritionAnti-Bacterial Agents0104 chemical sciences010404 medicinal & biomolecular chemistryStaphylococcus aureusBiofilmsPhenazinesMolecular MedicinebusinessChemMedChem
researchProduct

Prevention of nosocomial infections and surveillance of emerging resistances in NICU

2011

Neonates hospitalized in NICU are at risk for healthcare associated infections because of their poor immune defenses, related to gestational age, colonization of mucous membranes and skin with nosocomial microorganisms, exposure to antibiotics, invasive procedures and frequent contacts with healthcare workers (HCWs). Healthcare associated infections are the major source of morbidity and mortality in NICU in the developed world. Most infections are caused by Gram-positive organisms, fulminant sepsis are often associated to Gram-negative organisms, fungal sepsis occurs frequently in ELBW infants. Hand hygiene is the most important preventive procedure, nevertheless hand hygiene compliance amo…

Methicillin-Resistant Staphylococcus aureusmedicine.medical_specialtymedicine.drug_classprevention surveillance nosocomial infections resistance neonate multidrug resistant organisms methicillin resistant staphylococcus aureusmedia_common.quotation_subjectAntibioticsDrug resistancemedicine.disease_causeCommunicable Diseases EmergingSepsisSettore MED/38 - Pediatria Generale E SpecialisticaHygieneIntensive Care Units NeonatalHumansMedicineIntensive care medicinemedia_commonCross InfectionInfection Controlbusiness.industryTransmission (medicine)Infant NewbornObstetrics and GynecologyDrug Resistance Microbialmedicine.diseaseAntimicrobialMethicillin-resistant Staphylococcus aureusDrug Resistance MultiplePopulation SurveillancePediatrics Perinatology and Child HealthbusinessFluconazolemedicine.drugThe Journal of Maternal-Fetal & Neonatal Medicine
researchProduct

A New Nuclear Function of the Entamoeba histolytica Glycolytic Enzyme Enolase: The Metabolic Regulation of Cytosine-5 Methyltransferase 2 (Dnmt2) Act…

2009

Cytosine-5 methyltransferases of the Dnmt2 family function as DNA and tRNA methyltransferases. Insight into the role and biological significance of Dnmt2 is greatly hampered by a lack of knowledge about its protein interactions. In this report, we address the subject of protein interaction by identifying enolase through a yeast two-hybrid screen as a Dnmt2-binding protein. Enolase, which is known to catalyze the conversion of 2-phosphoglycerate (2-PG) to phosphoenolpyruvate (PEP), was shown to have both a cytoplasmatic and a nuclear localization in the parasite Entamoeba histolytica. We discovered that enolase acts as a Dnmt2 inhibitor. This unexpected inhibitory activity was antagonized by…

MethyltransferaseQH301-705.5ImmunologyEnolaseProtozoan ProteinsPolymerase Chain ReactionMicrobiologyEntamoeba histolyticaTwo-Hybrid System TechniquesGenetics and Genomics/EpigeneticsVirologyGeneticsImmunoprecipitationDNA (Cytosine-5-)-MethyltransferasesMicrobiology/ParasitologyBiology (General)Molecular BiologyMolecular Biology/DNA MethylationCell Nucleuschemistry.chemical_classificationbiologyEntamoeba histolyticaInfectious Diseases/Protozoal InfectionsMethylationRC581-607biology.organism_classificationTRNA MethyltransferasesEnolase 2EnzymechemistryBiochemistryPhosphopyruvate HydrataseSpectrometry Mass Matrix-Assisted Laser Desorption-IonizationParasitologyImmunologic diseases. AllergyNuclear localization sequenceResearch ArticlePLoS Pathogens
researchProduct

Activation of the lectin pathway in murine lupus nephritis.

2004

In systemic lupus erythematosus (SLE), hypocomplementaemia and complement deposition have been described both in man and in experimental models. A major involvement of the classical pathway of complement activation has been demonstrated in this disease, however relatively little is known about the involvement of the lectin pathway. Therefore in the present study we have analyzed the activity of all three pathways of complement activation in murine models of SLE. In the mouse, MBL is expressed in two forms, namely MBL-A and MBL-C. In the present study young and old MRL-lpr and control MRL+/+ mice were compared for the levels of complement activity with specific attention for the lectin pathw…

Mice Inbred MRL lprImmunologychemical and pharmacologic phenomenaurologic and male genital diseasesmedicine.disease_causeAutoimmunityClassical complement pathwayMiceImmune systemimmune system diseasesMurine lupusLectinsmedicineAnimalsskin and connective tissue diseasesMolecular BiologyAutoantibodiesChemistrybacterial infections and mycosesmedicine.diseaseLupus NephritisComplement systemLectin pathwayImmunologyAlternative complement pathwayNephritisMolecular immunology
researchProduct

Increase in gut microbiota after immune suppression in baculovirus-infected larvae.

2013

Spodoptera exigua microarray was used to determine genes differentially expressed in S. exigua cells challenged with the species-specific baculovirus SeMNPV as well as with a generalist baculovirus, AcMNPV. Microarray results revealed that, in contrast to the host transcriptional shut-off that is expected during baculovirus infection, S. exigua cells showed a balanced number of up- and down-regulated genes during the first 36 hours following the infection. Many immune-related genes, including pattern recognition proteins, genes involved in signalling and immune pathways as well as immune effectors and genes coding for proteins involved in the melanization cascade were found to be down-regul…

MicroarraysApplied MicrobiologyvirusesGut floraTranscriptomesBiology (General)Immune ResponseEffectorViral Immune EvasionMicrobiotaAgricultureGenomicsFunctional GenomicsHost-Pathogen InteractionIntestinesLarvaResearch ArticleQH301-705.5Mechanisms of Resistance and SusceptibilityImmunologyVirulenceBiologySpodopteraSpodopteraImmune SuppressionMicrobiologydigestive systemVirusMicrobiologyMolecular GeneticsImmune systemIntegrated ControlGenome Analysis ToolsVirologyMicrobial ControlExiguaGeneticsImmune ToleranceAnimalsGene RegulationMolecular BiologyGeneBiologyImmunity to InfectionsMicrobial PathogensImmunityComputational BiologyImmune DefenseRC581-607biology.organism_classificationNucleopolyhedrovirusesParasitologyPest ControlImmunologic diseases. AllergyGenome Expression AnalysisPLoS Pathogens
researchProduct

In vitro fungicidal activities of echinocandins against Candida metapsilosis, C. orthopsilosis, and C. parapsilosis evaluated by time-kill studies.

2010

ABSTRACT Anidulafungin, micafungin, and caspofungin in vitro activities against Candida metapsilosis , C. orthopsilosis , and C. parapsilosis were evaluated by MICs and time-kill methods. All echinocandins showed lower MICs (mean MICs, 0.05 to 0.71 mg/liter) and the highest killing rates (−0.06 to −0.05 CFU/ml/h) for C. metapsilosis and C. orthopsilosis rather than for C. parapsilosis (mean MICs, 0.59 to 1.68 mg/liter). Micafungin and anidulafungin killing rates were greater than those determined for caspofungin. None of the echinocandins had fungicidal activity against C. parapsilosis .

Microbiological TechniquesAntifungal AgentsTime FactorsMicrobial Sensitivity TestsIn Vitro TechniquesAnidulafunginMicrobiologychemistry.chemical_compoundEchinocandinsLipopeptidesCandida metapsilosisCaspofunginmedicinepolycyclic compoundsPharmacology (medical)CandidaPharmacologybiologyMicafunginFungi imperfectibiology.organism_classificationbacterial infections and mycosesIn vitroFungicideInfectious DiseaseschemistrySusceptibilityMicafunginAnidulafunginCaspofunginEchinocandinsmedicine.drugAntimicrobial agents and chemotherapy
researchProduct

Cardiovascular complications in COVID-19:A systematic review and meta-analysis

2020

Microbiology (medical)2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralBioinformaticsBetacoronavirusPandemicMedicineHumansCardiovascular complicationsPandemicsinfektiotauditRetrospective Studiesbiologybusiness.industrySARS-CoV-2COVID-19Covid19komplikaatiotbiology.organism_classificationCardiovascular diseaseInfectious Diseases/dk/atira/pure/core/keywords/uob_covid19Cardiovascular DiseasesMeta-analysissydän- ja verisuonitauditbusinessCoronavirus InfectionsBetacoronavirus
researchProduct

Oral antiseptics against coronavirus: in-vitro and clinical evidence

2021

Background Angiotensin converting enzyme II (ACE2) is the cellular receptor for SARS-CoV-2, so ACE2-expressing cells can act as target cells and are susceptible to infection. ACE2 receptors are highly expressed in the oral cavity so this may be a potential high-risk route for SARS-CoV-2 infection. Furthermore, the virus can be detected in saliva, even before COVID-19 symptoms appear, with the consequent high risk of virus transmission in asymptomatic/pre-symptomatic patients. Reducing oral viral load could lead to a lower risk of transmission via salivary droplets or aerosols and therefore contribute to the control of the pandemic. Aim To evaluate the available evidence testing the in vitro…

Microbiology (medical)2019-20 coronavirus outbreakmedicine.medical_specialtySalivaCoronavirus disease 2019 (COVID-19)coronavirusesSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)virusesMouthwashesCetylpyridiniumReviewmedicine.disease_causeLower riskViruslaw.inventionoral antisepticsRandomized controlled triallawInternal medicinemedicineHumansSalivaLetter to the EditorPandemicsPovidone-IodineCoronavirusMouthSARS-CoV-2Transmission (medicine)business.industryCOVID-19Hydrogen PeroxideGeneral MedicineViral LoadVirologyIn vitroCOVID-19 Drug TreatmentCoronavirusoral rinseInfectious DiseasesSystematic reviewClinical evidenceAnti-Infective Agents LocalCoronavirus InfectionsbusinessViral loadJournal of Hospital Infection
researchProduct